Duality Advisers, LP Bio N Tech Se Transaction History

Duality Advisers, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$102.58 - $129.66 $3.22 Million - $4.07 Million	31,382 New	31,382 $3.39 Million
Q4 2022 Feb 07, 2023	BUY	$118.43 - $186.05 $1.57 Million - $2.47 Million	13,267 Added 130.41%	23,440 $3.52 Million
Q3 2022 Nov 03, 2022	SELL	$127.65 - $183.11 $600,976 - $862,081	-4,708 Reduced 31.64%	10,173 $1.37 Million
Q2 2022 Aug 08, 2022	BUY	$123.25 - $186.24 $1.83 Million - $2.77 Million	14,881 New	14,881 $2.22 Million

364

39.6M

3.01M

2.01M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $23.1B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.